Product Information
ERY-TAB DR 333 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $3.5825 per EA under NDC 24338012403. Its NADAC has been published 173 times since Feb 7, 2018.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
333 mg/1
Manufacturer
Arbor Pharmaceuticals, Inc.NDC
24338012403
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298FDA Approved
Before 1982
TE Code
AB
On Market Since
4/18/2011
Pharmacological Classes
Price Statistics
The NADAC for ERY-TAB DR 333 MG TABLET has been published 173 times since Feb 7, 2018, and over the history we have for it it has declined 57.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5825 per EA |
|---|---|
| All-time high | $8.5150 (Jan 16, 2019) |
| All-time low | $2.5179 (Aug 21, 2024) |
| 52-week high | $3.7275 |
| 52-week low | $3.3321 |
| Median price | $3.6757 |
| Average price | $4.8779 |
| Largest weekly change | -60.1% (Apr 17, 2024) |
| Weeks tracked | 173 |
| Tracking since | Feb 7, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERY-TAB DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 333 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $3.5825 per EA (NDC 24338012403), effective Aug 19, 2026.
How has the price of ERY-TAB DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERY-TAB DR 333 MG TABLET has declined 57.9%. It has been tracked across 173 weekly CMS publications since Feb 7, 2018.
What are the highest and lowest recorded NADAC prices for ERY-TAB DR 333 MG TABLET?
Since Feb 7, 2018, the NADAC for ERY-TAB DR 333 MG TABLET has ranged from a low of $2.5179 (Aug 21, 2024) to a high of $8.5150 (Jan 16, 2019), with a median of $3.6757 per EA.
Are there cheaper alternatives to ERY-TAB DR 333 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ERY-TAB DR 333 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ERY-TAB DR 333 MG TABLET?
ERY-TAB DR 333 MG TABLET (NDC 24338012403) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.